Maximum quantity allowed is 999
Please select the quantity
CAS RN: 82248-59-7 | Product Number: A2357
Atomoxetine Hydrochloride
×
![]()
×
Purity: >98.0%(T)(HPLC)
Synonyms:
- (R)-N-Methyl-3-(2-methylphenoxy)-3-phenylpropylamine Hydrochloride
- (R)-Tomoxetine Hydrochloride
Product Documents:
| Size | Unit Price | Hyderabad | Japan* | Quantity |
|---|---|---|---|---|
| 100MG |
₹5,500.00
|
2 | ≥60 |
|
| 1G |
₹11,800.00
|
Contact Us | 29 |
|
*Upon orders receipt, Hyderabad stocks will be dispatched on the same day.
*Items available in Japan warehouse will be dispatched in 10-12 working days.
*INR price is exclusive of domestic taxes applicable.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
| Product Number | A2357 |
Purity / Analysis Method 
|
>98.0%(T)(HPLC) |
| Molecular Formula / Molecular Weight | C__1__7H__2__1NO·HCl = 291.82 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature
|
Frozen (<0°C) |
| Condition to Avoid | Heat Sensitive |
| Packaging and Container
|
100MG-Glass Bottle with Plastic Insert (View image) |
| CAS RN | 82248-59-7 |
| Related CAS RN
|
83015-26-3 |
| Reaxys Registry Number | 5318974 |
| PubChem Substance ID | 125307825 |
| Merck Index (14) | 863 |
| MDL Number | MFCD06410992 |
Specifications
| Appearance | White to Almost white powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Purity(Nonaqueous Titration) | min. 98.0 % |
| Melting point | 167.0 to 171.0 °C |
| Specific rotation [a]20/D | -41.0 to -44.0 deg(C=1, MeOH) |
Properties (reference)
| Melting Point | 169 °C |
| Specific Rotation | -42° (C=1,MeOH) |
| Solubility (soluble in) | Methanol |
GHS
Related Laws:
Transport Information:
Application
Atomoxetine Hydrochloride: A Selective Noradrenaline (Norepinephrine) Reuptake Inhibitor
Atomoxetine hydrochloride is a selective noradrenaline (norepinephrine, [A0906]) reuptake inhibitor (NRI). The selective inhibitions of the noradrenaline transporter (NAT) help to reverse the depletion of neurotransmitters at the synapse. There is evidence to suggest that atomoxetine shows beneficial effect for the treatment of attention-deficit/hyperactivity disorder (ADHD), but the precise mechanism is not fully understood. (The product is for research purpose only.)
References
- Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in Attention Deficit/Hyperactivity Disorder
- Atomoxetine: a review of its use in adults with attention deficit hyperactivity disorder
- The neuropharmacology of ADHD drugs in vivo: Insights on efficacy and safety (a review)
- A quality by design approach to impurity method development for atomoxetine hydrochloride (LY139603)
PubMed Literature
Product Articles
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.